Keyphrases
Zolpidem
100%
Neurometabolic
100%
Apathy
100%
Leukoencephalopathy
100%
Metabolism
37%
γ-aminobutyric Acid
37%
Orbitofrontal Cortex
37%
Magnetic Resonance Spectroscopy
25%
Frontal Cortex
25%
White Matter Disease
25%
Basal Ganglia
25%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
25%
Glutamine
25%
Activation Domain
12%
Glutamate
12%
Older Patients
12%
Clinical Effect
12%
Neurological Disorders
12%
Healthy Controls
12%
Autoactivation
12%
Pallidum
12%
Hypometabolism
12%
Dorsolateral
12%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
12%
Post-anoxic
12%
Anoxic Brain Injury
12%
Glutamate Metabolism
12%
Emotional Arousal
12%
Dorsolateral Cortex
12%
Genetic Leukoencephalopathies
12%
Cognitive Domains
12%
Symptomatic Effect
12%
Neuroscience
Zolpidem
100%
Leukoencephalopathy
100%
Metabolic Pathway
50%
Orbitofrontal Cortex
37%
Gamma-Aminobutyric Acid
37%
Positron Emission Tomography
37%
Basal Ganglia
25%
Frontal Lobe
25%
Glutamine
25%
Nuclear Magnetic Resonance Spectroscopy
25%
Glutamic Acid
25%
White Matter Disease
12%
Neurological Disorder
12%
Fluorine-18
12%
Cerebrovascular Accident
12%